Leonard Reyno is Chief Medical Officer of C4 Therapeutics, Inc.. Currently has a direct ownership of 173,764 shares of CCCC, which is worth approximately $470,900. The most recent transaction as insider was on Feb 14, 2025, when has been sold 5,145 shares (Common Stock) at a price of $3.18 per share, resulting in proceeds of $16,361. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 174K
89.27% 3M change
77.31% 12M change
Total Value Held $470,900

LEONARD REYNO Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 14 2025
SELL
Payment of exercise price or tax liability
$16,361 $3.18 p/Share
5,145 Reduced 2.88%
173,764 Common Stock
Feb 14 2025
BUY
Grant, award, or other acquisition
-
87,100 Added 32.74%
178,909 Common Stock
Jul 10 2024
SELL
Payment of exercise price or tax liability
$30,955 $5.0 p/Share
6,191 Reduced 6.32%
91,809 Common Stock
Feb 14 2024
BUY
Grant, award, or other acquisition
-
36,700 Added 27.25%
98,000 Common Stock
Jul 10 2023
BUY
Grant, award, or other acquisition
-
61,300 Added 50.0%
61,300 Common Stock
LR

Leonard Reyno

Chief Medical Officer
Watertown, MA

Track Institutional and Insider Activities on CCCC

Follow C4 Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CCCC shares.

Notify only if

Insider Trading

Get notified when an C4 Therapeutics, Inc. insider buys or sells CCCC shares.

Notify only if

News

Receive news related to C4 Therapeutics, Inc.

Track Activities on CCCC